Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NVCR
#4316
NovoCure Limited - Ordinary Shares
0.1
7
USD
-99.01%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-99.01%
Monthly Change
-98.72%
6 month change
-98.59%
Year Change
-98.76%
Previous Close
17.2
5
Open
0.1
7
Low
0.1
7
High
0.1
7
Volume
218
Markets
US Stock Market
Healthcare
NVCR
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
102.41 M
104.42 M
105.46 M
107.09 M
109.92 M
113.79 M
115.82 M
Valuation ratios
Enterprise value
17.92 B
8.19 B
7.61 B
1.87 B
3.77 B
1.57 B
2.2 B
Price to earnings ratio
961.33
-134.07
-77.2
-7.38
-19.1
-10.6
-11.81
Price to sales ratio
38.11
14.51
13.22
3.01
5.31
2.2
3.01
Price to cash flow ratio
190.02
93.84
230.95
-20.89
-121.87
-29.4
-75.66
Price to book ratio
39.54
18.92
16.12
4.23
8.92
4.23
1.49
Enterprise value to EBITDA ratio
477.14
-214.58
-91.61
-8.29
-23.3
-11.17
-10.87
Profitability ratios
Return on assets %
0.02
-0.05
-0.08
-0.18
-0.14
-0.17
-0.09
Return on equity %
0.04
-0.14
-0.21
-0.57
-0.47
-0.4
-0.22
Return on invested capital %
105.03
-149.65
-317.14
-702.9
-111.43
-316.69
-125.67
Gross margin %
78.46
78.53
78.64
74.81
77.33
74.54
77.63
Operating margin %
6.15
-8.29
-16.64
-45.72
-28.17
-23.47
-38.73
EBITDA margin %
7.6
-7.14
-15.46
-44.3
-26.72
-21.48
-40.24
Net margin %
4.01
-10.91
-17.2
-40.65
-27.86
-20.79
-40.87
Liquidity ratios
Quick ratio
8.56
7.36
6.82
5.56
1.42
2.71
2.7
Current ratio
8.8
7.53
7
5.78
1.46
2.9
2.9
Inventory turnover
0.02
0.04
0.01
0
0.01
0.08
—
Asset turnover
0.65
0.49
0.46
0.44
0.51
0.81
0.22
Solvency ratios
Debt to assets ratio
0.41
0.49
0.47
0.5
0.08
0.24
0.25
Debt to equity ratio
0.9
1.37
1.28
1.57
0.27
0.57
0.59
Long term debt to total assets ratio
0.41
0.49
0.47
0.5
0.53
0.24
0.25
Long term debt to total equity ratio
0.9
1.37
1.28
1.57
1.82
0.57
0.59
Per share metrics
Operating cash flow per share
0.91
0.8
0.29
-0.69
-0.24
-0.44
-0.24
EBIT per share
0.28
-0.43
-0.86
-2.19
-1.58
-1.38
-1.63
EBITDA per share
0.34
-0.37
-0.79
-2.12
-1.5
-1.26
-1.8
Total debt per share
3.95
5.44
5.4
5.35
6.08
1.75
1.71
Cash per share
7.74
9.07
9.26
8.56
8.9
4.02
3.78
Net current asset value per share
9.18
10.38
10.62
9.72
10.26
5.8
5.53
Tangible book value per share
4.38
3.97
4.22
3.41
3.34
3.05
2.9
Working capital per share
8.14
9
9.1
8.04
3.25
3.8
3.63
Book value per share
4.38
3.97
4.22
3.41
3.34
3.05
2.9
News
International Markets and NovoCure (NVCR): A Deep Dive for Investors
NovoCure Stock Shows Strength With RS Upgrade; Investors Should Watch For Next Entry
Two Medical Stocks Skyrocket After Demolishing Views — And One Is About To Break Out
NovoCure (NVCR) Reports Q1 Loss, Beats Revenue Estimates
Humacyte, Inc. (HUMA) Reports Q4 Loss, Misses Revenue Estimates
Novocure at Leerink Conference: Strategic Growth in Cancer Treatment
Novocure's Optune Lua Gets Japan Reimbursement for NSCLC Treatment
NovoCure (NVCR) Reliance on International Sales: What Investors Need to Know
Novocure gains Japan reimbursement for Optune Lua device
NovoCure (NVCR) Reports Q4 Loss, Beats Revenue Estimates
NovoCure Limited (NVCR) Q4 2025 Earnings Call Transcript
Novocure Ltd earnings beat by $0.19, revenue topped estimates